Study

EORTC-30962

Comparative study of intravesical BCG standard dose long-term maintenance versus BCG 1/3 dose long-term maintenance versus BCG standard dose short-term maintenance versus BCG 1/3 dose short-term maintenance in intermediate and high risk Ta- T1 Papillary Carcinoma of the Urinary Bladder.

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 01-Mar-1997
Date Step1 close: 04-Apr-2005

Data management at EORTC

Yes

Design

Phase 3
Randomized open label

Targeted Sample size

EORTC Groups: 1288

Protocol summary

http://clinicaltrials.gov/study/NCT00002990

NCT number

NCT00002990